Shijiazhuang Yiling Pharmaceutical Co Ltd Strategic Asset Allocation Index

Latest as of September 2023: 59.1%

Shijiazhuang Yiling Pharmaceutical Co Ltd strategic asset allocation index. Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) has a Strategic Asset Allocation Index of 59.1% as of September 2023. Strategic assets (PP&E of CN¥7.00 Billion plus long-term investments of CN¥-) total CN¥7.00 Billion, measured against net assets of CN¥11.85 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Shijiazhuang Yiling Pharmaceutical Co Lt (002603) balance sheet quality index to measure how much of total assets are equity-financed.

SAAI

59.1%
Strategic Assets / Net Assets

Strategic Assets

CN¥7.00 Billion
PP&E + LT Investments

PP&E

CN¥7.00 Billion
CNY

Net Assets

CN¥11.85 Billion
CNY

Strategic Asset Allocation Index of Shijiazhuang Yiling Pharmaceutical Co Ltd (2008–2021)

Strategic asset allocation index of Shijiazhuang Yiling Pharmaceutical Co Ltd from 2008 to 2021. This chart shows how Shijiazhuang Yiling Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 14 annual periods from 2008 to 2021. As of September 2023, the index stands at 59.1%, representing strategic assets of CN¥7.00 Billion against net assets of CN¥11.85 Billion CNY. Check Shijiazhuang Yiling Pharmaceutical Co Lt tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Shijiazhuang Yiling Pharmaceutical Co Ltd Strategic Asset Allocation Index by Year (2008–2021)

Shijiazhuang Yiling Pharmaceutical Co Ltd strategic asset allocation index by year from 2008 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Shijiazhuang Yiling Pharmaceutical Co Ltd from 2008 to 2021, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of Shijiazhuang Yiling Pharmaceutical Co Lt.

Year SAAI Strategic Assets (CNY) PP&E LT Investments Net Assets Change (pp)
2021 63.5% CN¥5.76 Billion CN¥5.76 Billion CN¥- CN¥9.07 Billion ▲ +15.1 pp
2020 48.3% CN¥4.31 Billion CN¥4.31 Billion CN¥- CN¥8.92 Billion ▲ +9.9 pp
2019 38.5% CN¥3.06 Billion CN¥3.06 Billion CN¥- CN¥7.95 Billion ▼ 0.0 pp
2018 38.5% CN¥2.91 Billion CN¥2.86 Billion CN¥50.46 Million CN¥7.56 Billion ▼ -5.0 pp
2017 43.6% CN¥3.10 Billion CN¥3.01 Billion CN¥90.60 Million CN¥7.11 Billion ▼ -14.4 pp
2016 57.9% CN¥3.09 Billion CN¥3.02 Billion CN¥69.02 Million CN¥5.33 Billion ▲ +1.2 pp
2015 56.7% CN¥2.74 Billion CN¥2.73 Billion CN¥2.52 Million CN¥4.83 Billion ▲ +12.2 pp
2014 44.5% CN¥1.97 Billion CN¥1.97 Billion CN¥- CN¥4.42 Billion ▲ +1.3 pp
2013 43.2% CN¥1.84 Billion CN¥1.84 Billion CN¥- CN¥4.26 Billion ▲ +6.1 pp
2012 37.1% CN¥1.42 Billion CN¥1.42 Billion CN¥- CN¥3.84 Billion ▲ +9.5 pp
2011 27.5% CN¥1.02 Billion CN¥1.02 Billion CN¥- CN¥3.70 Billion ▼ -51.2 pp
2010 78.7% CN¥858.80 Million CN¥858.80 Million CN¥- CN¥1.09 Billion ▲ +7.6 pp
2009 71.1% CN¥562.09 Million CN¥562.09 Million CN¥- CN¥790.55 Million ▼ -5.5 pp
2008 76.6% CN¥370.91 Million CN¥370.91 Million CN¥- CN¥484.03 Million —
pp = percentage points